spacer
spacer
START logoA clinical research study of thymoglobulin to arrest type 1 diabetes


 

Contact Us

If you believe you may be eligible and would like more information about participating in the START trial for new onset type 1 diabetes, contact us at the study site nearest you. Additional sites in California and Pennsylvania will be open soon.

CALIFORNIA

San Francisco
The Diabetes Center at UCSF [map]
Contact: Kathleen Fraser
Phone: (415) 353-9084
Email: ucsf@type1diabetestrial.org

Oakland
Children's Hospital and Research Center [map]
Contact: Betty Flores
Phone: 510-428-3885 ext 4694
Email: oakland@type1diabetestrial.org

San Diego
UCSD/San Diego Children’s Hospital [map]
Contact: Marla Hashiguchi
Phone: (858) 966-8940
Email: ucsd@type1diabetestrial.org

Los Angeles
Children’s Hospital/USC School of Medicine [map]
Contact: Mary Halvorson or Christine Salazar
Phone: (323) 361-5961
Email: chla@type1diabetestrial.org

COLORADO

Denver
Barbara Davis Center for Childhood Diabetes [map]
Contact: Amy Wallace, MA
Phone: (303) 724-6768
Email: denver@type1diabetestrial.org

GEORGIA

Atlanta
Emory Children's Center [map]
Contact: Gregory A. Smallwood, PharmD
Phone: (404) 785-T1DM (8136)
Email: type1diabetes@emory.edu

MISSOURI / KANSAS

Kansas City
Children’s Mercy Hospital [map]
Contact: Sue Ellen Weigel
Phone: (816) 234-3975
Email: kansascity@type1diabetestrial.org

MINNESOTA

Minneapolis
University of Minnesota [map]
Contact: Carrie Gibson
Phone: (612) 624-5958
Email: umn@type1diabetestrial.org

PENNSYLVANIA

Philadelphia
University of Pennsylvania/Children’s Hospital of Philadelphia [map]
Contact: Ahmad Khan, RN
Phone: (215) 590-5007
Email: upenn@type1diabetestrial.org

CONNECTICUT

New Haven
Yale University [map]
Contact: Linda Rink, RN
Phone: (203) 737-4510
Email: linda.rink@yale.edu

 


View Larger Map

spacer
spacer
 
Terms of Use | Privacy | Accessibility
©2007, Immune Tolerance Network
spacer